Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
Clinical trial NCT00724568 · COMPLETED
Trial details
- NCT number
- NCT00724568
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.